# Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail

> **NCT02789189** · PHASE2 · TERMINATED · sponsor: **Sun Yat-sen University** · enrollment: 60 (estimated)

## Conditions studied

- Recurrent and Metastatic Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** nedaplatin and gemcitabine

## Key facts

- **NCT ID:** NCT02789189
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2019-09-04
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02789189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02789189, "Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02789189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*